This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jul;59(1):1-2.

doi: 10.1016/j.jhep.2013.04.008. Epub 2013 Apr 11.

Focus

Scott L Friedman¹

Affiliations

PMID: 23583274
DOI: 10.1016/j.jhep.2013.04.008

Comment

Focus

Scott L Friedman. J Hepatol. 2013 Jul.

. 2013 Jul;59(1):1-2.

doi: 10.1016/j.jhep.2013.04.008. Epub 2013 Apr 11.

Author

Scott L Friedman¹

Affiliation

¹ Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA. scott.friedman@mssm.edu

PMID: 23583274
DOI: 10.1016/j.jhep.2013.04.008

No abstract available

PubMed Disclaimer

Comment on

Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.
Chrispijn M, Gevers TJ, Hol JC, Monshouwer R, Dekker HM, Drenth JP. Chrispijn M, et al. J Hepatol. 2013 Jul;59(1):153-9. doi: 10.1016/j.jhep.2013.03.004. Epub 2013 Mar 14. J Hepatol. 2013. PMID: 23499726 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information